这样，我好对照朋友情况看看她是否适合接受这种治疗。
Conditions treated
The FDA-approved indications for CAR T-cell therapy, Yescarta made by Kite Pharma Gilead, is aggressive B-cell non-Hodgkin's lymphoma, including the diagnosis of:
- Diffuse large B-cell lymphoma
- Primary mediastinal B-cell lymphoma
- Large B-cell lymphoma transformed from follicular lymphoma
- Aggressive B-cell lymphoma not otherwise specified (NOS)
Patients who have relapsed or refractory disease after two or more types of prior treatments could be evaluated for CAR T-cell therapy with Yescarta.
In addition, Mayo Clinic has multiple active clinical trials testing CAR T-cell therapy in lymphoma and other cancer types.
请问：
“including the diagnosis of:
- Diffuse large B-cell lymphoma
- Primary mediastinal B-cell lymphoma
- Large B-cell lymphoma transformed from follicular lymphoma
- Aggressive B-cell lymphoma not otherwise specified (NOS)”
这段话是什么意思啊？是这种疗法要做的事？这种疗法需要的前提？还是这种疗法需要确诊上述问题？
拜谢！
